Novel, acidic CCR2 receptor antagonists: From hit to lead

被引：15
|
作者：
Zou, D.
Zhai, H. A.
Eckman, J.
Higgins, P.
Gillard, M.
Knerr, L.
Carre, S.
Pasau, P.
Collart, P.
Grassi, J.
Libertine, L.
Nicolas, J. -M.
Schwartz, C. E.
机构：
[1] UCB Res Inc, Cambridge, MA 02139 USA
[2] UCB Pharma, B-1420 Braine lAlleud, Belgium
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2007年 / 4卷 / 03期
关键词：
MCP-1; CCR2; chemokine receptor; antagonist; inflammation; hit to lead;
D O I：
10.2174/157018007780077381
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
引用
收藏
页码：185 / 191
页数：7
相关论文
共 50 条
  • [21] Design, synthesis, and structure-activity relationship of novel CCR2 antagonists
    Kothandaraman, Shankaran
    Donnely, Karla L.
    Butora, Gabor
    Jiao, Richard
    Pasternak, Alexander
    Morriello, Gregori J.
    Goble, Stephen D.
    Zhou, Changyou
    Mills, Sander G.
    MacCoss, Malcolm
    Vicario, Pasquale P.
    Ayala, Julia M.
    DeMartino, Julie A.
    Struthers, Mary
    Cascieri, Margaret A.
    Yang, Lihu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1830 - 1834
  • [22] The discovery of CCR5 receptor antagonists for the treatment of HIV infection: Hit-to-lead studies
    Armour, Duncan
    de Groot, Marcel J.
    Edwards, Martin
    Perros, Manos
    Price, David A.
    Stammen, Blanda L.
    Wood, Anthony
    CHEMMEDCHEM, 2006, 1 (07) : 706 - +
  • [23] Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2)
    Strunz, Ann Kathrin
    Zweemer, Annelien J. M.
    Weiss, Christina
    Schepmann, Dirk
    Junker, Anna
    Heitman, Laura H.
    Koch, Michael
    Wuensch, Bernhard
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (14) : 4034 - 4049
  • [24] α-Aminothiazole-γ-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists
    Zhou, Changyou
    Guo, Liangqin
    Parsons, William H.
    Mills, Sander G.
    MacCoss, Malcolm
    Vicario, Pasquale P.
    Zweerink, Hans
    Cascieri, Margaret A.
    Springer, Martin S.
    Yang, Lihu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 309 - 314
  • [25] CCR2 receptor antagonists: Optimization of biaryl sulfonamides to increase activity in whole blood
    Wang, Gren Z.
    Haile, Pamela A.
    Daniel, Tom
    Belot, Benjamin
    Viet, Andrew Q.
    Goodman, Krista B.
    Sha, Deyou
    Dowdell, Sarah E.
    Varga, Norbert
    Hong, Xuan
    Chakravorty, Subhas
    Webb, Christine
    Cornejo, Carla
    Olzinski, Alan
    Bernard, Roberta
    Evans, Christopher
    Emmons, Amanda
    Briand, Jacques
    Chung, Chun-Wa
    Quek, Ruben
    Lee, Dennis
    Gough, Peter J.
    Sehon, Clark A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7291 - 7294
  • [26] Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists
    Junker, Anna
    Kokornaczyk, Artur K.
    Zweemer, Annelien J. M.
    Frehland, Bastian
    Schepmann, Dirk
    Yamaguchi, Junichiro
    Itami, Kenichiro
    Faust, Andreas
    Hermann, Sven
    Wagner, Stefan
    Schaefers, Michael
    Koch, Michael
    Weiss, Christina
    Heitman, Laura H.
    Kopka, Klaus
    Wuensch, Bernhard
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (08) : 2407 - 2422
  • [27] Substituted dipiperidine alcohols as potent CCR2 antagonists
    Xia, Mingde
    Hou, Cuifen
    DeMong, Duane
    Pollack, Scott
    Pan, Meng
    Brackley, James
    Singer, Monica
    Matheis, Michele
    Cavender, Druie
    Wachter, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3562 - 3564
  • [28] In vivo activity of an azole series of CCR2 antagonists
    Smethurst, Chris A.
    Bevan, Nicola
    Brooks, Carl
    Emmons, Amanda
    Gough, Peter J.
    Mookherjee, Claudette
    Moores, Kitty
    Peace, Simon
    Philp, Joanne
    Piercy, Val
    Watson, Steve P.
    Zippoli, Mara
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7252 - 7255
  • [29] Longer Receptor Residence Times Improve the Effectiveness of CCR2 Antagonists in the Prevention of Atherosclerosis
    Bot, Ilze
    Zacarias, Natalia V. Ortiz
    de Vries, Henk
    van Santbrink, Peter J.
    van der Velden, Daniel
    Kuiper, Johan
    Stamos, Dean
    Ijzerman, Adriaan P.
    Heitman, Laura H.
    CIRCULATION, 2015, 132
  • [30] Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Voss, Matthew E.
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Tebben, Andrew J.
    Carter, Percy H.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3418 - 3422
12345